12 unknown. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Unknown 12 |
Follow Dermatitis, Atopic: new trials by email Literature Review of Dermatitis, Atopic trials Research Report on Dermatitis, Atopic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patients Dupilumab, Tofacitinib - Atopic Dermatitis | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 220 | 2025-01-01 | 2024-06-20 |
| Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models Second-line systemic treatment, Folllow-up of second-line systemic treatment already started - Atopic Dermatitis | Phase 4 | Unknown | Instituto de Investigación Hospital Universitario La Paz | 150 | 2023-09-25 | 2024-04-16 |
| Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis Dicloxacillin Oral Capsule, Elocon 0.1 % Topical Cream - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 4 | Unknown | Jacob Pontoppidan Thyssen | 45 | 2022-10-24 | 2022-12-21 |
| Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response Cyclosporin A, Follow-up of Cyclospoin treatment already started - Atopic Dermatitis | Phase 4 | Unknown | Instituto de Investigación Hospital Universitario La Paz | 100 | 2022-10-10 | 2023-04-28 |
| Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. Dupilumab, Optical Coherence Tomography, Reflectance confocal microscopy - Eczema, Atopic Dermatitis | Phase 4 | Unknown | OptiSkin Medical | 15 | 2022-03-01 | 2022-03-03 |
| Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood Methotrexate therapy, Mycophenolate mofetil therapy, Cyclosporine therapy - Atopic Dermatitis | Phase 4 | Unknown | National Medical Research Center for Children's Health, Russian Federation | 160 | 2021-11-25 | 2021-05-20 |
| An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis Dupilumab Only Product - Atopic Dermatitis, AD | Phase 4 | Unknown | Eric Simpson | 45 | 2020-09-01 | 2020-08-20 |
| Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children probiotics, conventional medical treatment - Rhinitis, Allergic, Asthma | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 200 | 2020-03-01 | 2021-06-24 |
| Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis Crisaborole 2% Top Oint - Atopic Dermatitis | Phase 4 | Unknown | Massachusetts General Hospital | 150 | 2020-02-03 | 2021-02-24 |
| Efficacy of Topical Coal Tar in Children With Atopic Dermatitis Topical coal tar, Topical corticosteroids - Atopic Dermatitis | Phase 4 | Unknown | Radboud University Medical Center | 80 | 2018-02-01 | 2018-03-12 |
| Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD) KAM2904 Face Cream, KAM3008 Body Lotion, petrolatum-based moisturizer - Atopic Dermatitis | Phase 4 | Unknown | Kamedis Ltd. | 56 | 2013-02-01 | 2014-01-30 |
| Effect of Moisturizing Creams on Skin Barrier Function urea/lactic acid, Placebo - Atopic Eczema | Phase 4 | Unknown | ACO Hud Nordic AB | 2008-10-13 |
Eczema (2) · Asthma (1) · Dermatitis (1) · Hypersensitivity (1) · Rhinitis, Allergic (1) · Staphylococcal Infections (1) · Urticaria (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12) · Genetic Diseases, Inborn (12) · Hypersensitivity, Immediate (12) · Immune System Diseases (12) · Skin Diseases (12) · Skin Diseases, Eczematous (12) · Skin Diseases, Genetic (12) · Skin and Connective Tissue Diseases (12) · Dermatitis (11) · Hypersensitivity (11) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bronchial Diseases (1) · Gram-Positive Bacterial Infections (1) · Infections (1)
dupilumab (4) · Adrenal Cortex Hormones (1) · Coal Tar (1) · Cyclosporine (1) · Dicloxacillin (1) · Longitudinal Studies (1) · Mometasone Furoate (1) · Probiotics (1) · Tomography, Optical Coherence (1) · abrocitinib (1) · baricitinib (1) · crisaborole (1) · tofacitinib (1) · tralokinumab (1) · upadacitinib (1)
Instituto de Investigación Hospital Universitario La Paz (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · ACO Hud Nordic AB (1) · Eric Simpson (1) · Jacob Pontoppidan Thyssen (1) · Kamedis Ltd. (1) · Massachusetts General Hospital (1) · National Medical Research Center for Children's Health, Russian Federation (1) · OptiSkin Medical (1) · Radboud University Medical Center (1)
Spain (3) · United States (2) · China (1) · Denmark (1) · Netherlands (1) · Russia (1) · Sweden (1)
Alberto M Borobia, MD, PhD (1) · Eric Simspon, MD (1) · Jacob Thyssen, Professor, MD, DMSc (1) · Orit Markowitz, MD (1) · Prof. Eli Sprecher, MD (1)